4 Key Priorities for Fighting Superbugs in 2021

  15 January 2021

Over the past year, COVID-19 has taken a grave toll in lives as well as on medical and health care systems worldwide. The pandemic has laid bare the importance of public health readiness and the myriad consequences when such a crisis strikes an unprepared population.

Even as the world is working to defeat COVID-19, another global health threat is lurking: antibiotic resistance. In the United States in recent years, there has been bipartisan momentum to prioritize the fight against superbugs that do not respond to available antibiotics, and now—more than ever—progress must not slow.  

Policymakers and other stakeholders must learn from the pandemic and not hesitate in putting those insights to work. 

Further reading: PEW
Author(s): David Hyun
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





EADA 2023

Emerging Antimicrobials and Diagnostics in AMR 2023

International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!